Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prostavasin in dry age-related macular degeneration
2005-005686-11Phase 3Terminated
- Sponsor
- Schwarz Pharma
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Vasostenoon in age-related macular degeneration (AMD), sponsored by Schwarz Pharma. Started Mar 2006; status: terminated.
02
Drugs
Vasostenoon
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on 2005-005686-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005686-11.